These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1617912)

  • 1. Long-term dobutamine therapy for refractory congestive heart failure.
    Pickworth KK
    Clin Pharm; 1992 Jul; 11(7):618-24. PubMed ID: 1617912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE; Papalia U; Schiariti M; Usta C;
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
    Collins JA; Skidmore MA; Melvin DB; Engel PJ
    J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results.
    Miller LW
    J Heart Lung Transplant; 1991; 10(3):482-7. PubMed ID: 1854777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
    Tsagalou EP; Anastasiou-Nana MI; Terrovitis JV; Nanas SN; Alexopoulos GP; Kanakakis J; Nanas JN
    Int J Cardiol; 2006 Apr; 108(2):244-50. PubMed ID: 16023232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term dobutamine therapy in severe cardiac insufficiency].
    Weiss P; Schmidlin O; Ha HR; Ritz R; Follath F
    Schweiz Med Wochenschr; 1990 Feb; 120(6):190-3. PubMed ID: 2305231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient dobutamine for end-stage congestive heart failure.
    Miller LW; Merkle EJ; Herrmann V
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S30-3. PubMed ID: 2293976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
    Marcon JL; Bonijoly S; Favre E
    Ann Cardiol Angeiol (Paris); 1993 Nov; 42(9):495-502. PubMed ID: 8122866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
    Coffin MR
    J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of submaximal exercise capacity in patients with left ventricular assist devices.
    Foray A; Williams D; Reemtsma K; Oz M; Mancini D
    Circulation; 1996 Nov; 94(9 Suppl):II222-6. PubMed ID: 8901750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
    Colucci WS; Leatherman GF; Ludmer PL; Gauthier DF
    Circ Res; 1987 Oct; 61(4 Pt 2):I82-6. PubMed ID: 3652407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.